USFDA gives approval for Calcipotriene and Betamethasone foam

Glenmark’s current portfolio consists of 183 products authorized for distribution in the US marketplace and 45 ANDA’s pending approval with the USFDA.

166
USFDA Approval
USFDA Approval

Last Updated on October 15, 2024 by The Health Master

Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global pharmaceuticals company, has received final approval by the United States Food & Drug Administration (USFDA) for calcipotriene and betamethasone dipropionate foam, 0.005%|0.064, the generic version of Enstilar foam, 0.005%|0.064%, of Leo Pharma AS.

With respect to 180-day generic drug exclusivity, the USFDA noted that Glenmark was the first ANDA applicant to submit a substantially complete ANDA with a paragraph IV certification for calcipotriene and betamethasone dipropionate foam, 0.005%|0.064%.

Therefore, with this approval, Glenmark is eligible for 180-days of generic drug exclusivity for calcipotriene and betamethasone dipropionate foam, 0.005%|0.064%.

Glenmark’s current portfolio consists of 183 products authorized for distribution in the US marketplace and 45 ANDA’s pending approval with the USFDA.

In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

USFDA gives approval for Brexpiprazole tablets

USFDA gives approval for generic Rocuronium Bromide Injection

USFDA gives approval for Prochlorperazine Maleate Tablets USP

USFDA gives approval for Ranolazine ER tablets

USFDA gives nod for Human Trial of drug for the treatment of advanced cancer

USFDA gives approval for Clindamycin Hydrochloride Capsules

West Bengal notice to Pharma Industry on bio-resource use

USFDA gives approval for Brexpiprazole tablets

Govt constitutes panel for PLI scheme for pharmaceuticals

USFDA gives approval for generic Rocuronium Bromide Injection

Difference: Disintegration and Dissolution test in pharma industry

USFDA gives approval for Prochlorperazine Maleate Tablets USP

New study on the effectiveness of Homoeopathy Medicines

How to prepare SOPs in the Pharma Industry

Difference between branded and generic medicines

Understanding DQ, IQ, PQ, and OQ in the Pharma Industry

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news